A Study to Assess Long-Term Safety of the CyPass Micro-Stent in Patients Completing the COMPASS Trial
Public ClinicalTrials.gov record NCT02700984. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Observational Multicenter Clinical Study to Assess the Long-Term Safety of the CyPass Micro-Stent in Patients With Primary Open Angle Glaucoma Who Have Completed Participation in the COMPASS Trial
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the long-term safety of the CyPass Micro-Stent in subjects who completed Study Protocol TMI-09-01, COMPASS Trial.
Study identification
- NCT ID
- NCT02700984
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 282 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 45 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 30, 2016 (Actual)
- Primary completion
- Apr 18, 2018 (Actual)
- Completion
- Apr 18, 2018 (Actual)
- Last update posted
- Jan 24, 2024
2016 – 2018
United States locations
- U.S. sites
- 22
- U.S. states
- 15
- U.S. cities
- 22
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Alcon Investigative Site | Glendale | Arizona | 85306 | — |
| Alcon Investigative Site | Fayetteville | Arkansas | 72704 | — |
| Alcon Investigative Site | La Jolla | California | 92037 | — |
| Alcon Investigative Site | Orange | California | 92868 | — |
| Alcon Investigative Site | Fort Collins | Colorado | 80525 | — |
| Alcon Investigative Site | Parker | Colorado | 80134 | — |
| Alcon Investigative Site | Boynton Beach | Florida | 33426 | — |
| Alcon Investigative Site | Cape Coral | Florida | 33904 | — |
| Alcon Investigative Site | Sioux City | Iowa | 51104 | — |
| Alcon Investigative Site | Garden City | Kansas | 67846 | — |
| Alcon Investigative Site | Boston | Massachusetts | 02111 | — |
| Alcon Investigative Site | St Louis | Missouri | 63131 | — |
| Alcon Investigative Site | Vineland | New Jersey | 08361 | — |
| Alcon Investigative Site | Cincinnati | Ohio | 45242 | — |
| Alcon Investigative Site | Oklahoma City | Oklahoma | 73104 | — |
| Alcon Investigative Site | Kingston | Pennsylvania | 18704 | — |
| Alcon Investigative Site | West Mifflin | Pennsylvania | 15122 | — |
| Alcon Investigative Site | Maryville | Tennessee | 37803 | — |
| Alcon Investigative Site | Nashville | Tennessee | 37232 | — |
| Alcon Investigative Site | Dallas | Texas | 75231 | — |
| Alcon Investigative Site | Fort Worth | Texas | 76102 | — |
| Alcon Investigative Site | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02700984, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 24, 2024 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02700984 live on ClinicalTrials.gov.